Literature DB >> 1348968

Soluble intercellular adhesion molecule 1 is released by human melanoma cells and is associated with tumor growth in nude mice.

R Giavazzi1, R G Chirivi, A Garofalo, A Rambaldi, I Hemingway, R Pigott, A J Gearing.   

Abstract

We have studied the cytokine regulation of cell surface and soluble intercellular adhesion molecule 1 (ICAM-1) expression on the human melanoma cell line A375M. Unstimulated cells express ICAM-1 on their cell surface but do not secrete significant levels of soluble ICAM-1. Interleukin 1, interleukin 6, tumor necrosis factor, and gamma-interferon all increased cell surface expression of ICAM-1. Tumor necrosis factor, interleukin 1, and gamma-interferon also caused the release of soluble ICAM-1. The serum of melanoma patients has been reported to contain elevated levels of soluble ICAM-1; however, the source of this ICAM-1 is unclear. The serum from nude mice bearing s.c. human melanoma tumors was found to contain soluble human ICAM-1. ICAM-1 levels showed a positive correlation with tumor weight. The release of ICAM-1 from melanoma tumors, in response to host-derived cytokines, may have relevance to immune recognition of the tumor.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1348968

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  20 in total

Review 1.  Technical considerations for studying cancer metastasis in vivo.

Authors:  D R Welch
Journal:  Clin Exp Metastasis       Date:  1997-05       Impact factor: 5.150

2.  A randomized phase II dose-response exercise trial among colon cancer survivors: Purpose, study design, methods, and recruitment results.

Authors:  Justin C Brown; Andrea B Troxel; Bonnie Ky; Nevena Damjanov; Babette S Zemel; Michael R Rickels; Andrew D Rhim; Anil K Rustgi; Kerry S Courneya; Kathryn H Schmitz
Journal:  Contemp Clin Trials       Date:  2016-03-10       Impact factor: 2.226

3.  Association between ICAM-1 expression and metastatic capacity of murine B-cell hybridomas.

Authors:  R G Hawley; M H Wang; A Z Fong; T S Hawley
Journal:  Clin Exp Metastasis       Date:  1993-03       Impact factor: 5.150

Review 4.  Intercellular adhesion molecule-1.

Authors:  A van de Stolpe; P T van der Saag
Journal:  J Mol Med (Berl)       Date:  1996-01       Impact factor: 4.599

5.  Stimulation of intercellular adhesion molecule-1 (ICAM-1) antigen expression and shedding by interferon-gamma and phorbol ester in human renal carcinoma cell cultures: relation to peripheral blood mononuclear cell adhesion.

Authors:  A B Hansen; S T Lillevang; C B Andersen
Journal:  Urol Res       Date:  1994

6.  Further characterization of a clinically relevant model of melanoma metastasis and an effective vaccine.

Authors:  D Shrayer; H Bogaars; V J Hearing; A Maizel; H Wanebo
Journal:  Cancer Immunol Immunother       Date:  1995-05       Impact factor: 6.968

Review 7.  Melanoma biomarkers: current status and utility in diagnosis, prognosis, and response to therapy.

Authors:  Nikolas K Haass; Keiran S M Smalley
Journal:  Mol Diagn Ther       Date:  2009       Impact factor: 4.074

8.  Intact transmembrane isoforms of the neural cell adhesion molecule are released from the plasma membrane.

Authors:  M Olsen; L Krog; K Edvardsen; L T Skovgaard; E Bock
Journal:  Biochem J       Date:  1993-11-01       Impact factor: 3.857

9.  Circulating soluble adhesion molecules E-cadherin, E-selectin, intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) in patients with gastric cancer.

Authors:  G Velikova; R E Banks; A Gearing; I Hemingway; M A Forbes; S R Preston; M Jones; J Wyatt; K Miller; U Ward; J Al-Maskatti; S M Singh; N S Ambrose; J N Primrose; P J Selby
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

10.  Enhancement of experimental metastasis by tumor necrosis factor.

Authors:  P Orosz; B Echtenacher; W Falk; J Rüschoff; D Weber; D N Männel
Journal:  J Exp Med       Date:  1993-05-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.